Literature DB >> 22507181

Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.

Paolo Angeli1, Arun Sanyal, Soren Moller, Carlo Alessandria, Adrian Gadano, Ray Kim, Shiv K Sarin, Mauro Bernardi.   

Abstract

Advanced cirrhosis is often complicated by a multi organ failure syndrome which involves many different organs besides the liver. The high morbidity and mortality secondary to this clinical setting is often related to renal dysfunction, either alone or, more frequently, in combination with other organ dysfunction. A clear definition of renal dysfunction, an accurate differential diagnostic process of its different phenotypes as well as of full understanding of its pathophysiological mechanisms are crucial to the development of strategies for the management of this complication. This article is based either on the more recent knowledge on renal dysfunction in advanced cirrhosis or current opinions among the members of the International Club of Ascites (ICA) on the management of this complication, obtained through a survey and discussed during the EASL-ICA Joint Meeting in Berlin in March 2011. It reviews critically our current knowledge and it outlines future perspectives, on the management of renal dysfunction in patients with cirrhosis.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22507181     DOI: 10.1111/j.1478-3231.2012.02807.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  21 in total

Review 1.  Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Authors:  Louise Madeleine Risør; Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2014-09-27       Impact factor: 6.047

Review 2.  Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system.

Authors:  Masayuki Ishii; Toru Mizuguchi; Kohei Harada; Shigenori Ota; Makoto Meguro; Tomomi Ueki; Toshihiko Nishidate; Kenji Okita; Koichi Hirata
Journal:  World J Hepatol       Date:  2014-10-27

Review 3.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Diabetes increases renovascular impedance in patients with liver cirrhosis.

Authors:  Luisa Spadaro; Graziella Privitera; Giuseppe Fede; Orazio Magliocco; Maurizio Russello; Salvatore Piro; Agata Maria Rabuazzo; Francesco Purrello
Journal:  Intern Emerg Med       Date:  2015-04-12       Impact factor: 3.397

Review 5.  Renal dysfunction in patients with cirrhosis: Where do we stand?

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

Review 6.  Cirrhotic Multiorgan Syndrome.

Authors:  Søren Møller; Flemming Bendtsen
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

7.  Treatment to improve acute kidney injury in cirrhosis.

Authors:  Florence Wong
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

8.  Influencing factors of transient elastography in detecting liver stiffness.

Authors:  Rong Shan; Hong Yin; Wenjuan Yang; Jianzhi Li; Meifang Zhang; Min Zhao; Jiang Shao; Aiguang Wang
Journal:  Exp Ther Med       Date:  2016-08-24       Impact factor: 2.447

Review 9.  Comorbidity in cirrhosis.

Authors:  Peter Jepsen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome.

Authors:  Abhasnee Sobhonslidsuk
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.